Reckitt Benckiser Group PLC

Chart & Performance

D1W1MN

P/E

4.01

P/S

0.45

EPS

2.39

Div Yield, %

16.21%

Shrs. gr., 5y

0.26%

Rev. gr., 5y

3.01%

Revenues

14.61b

+1.07%

Net income

1.64b

-29.48%

CFO

2.64b

+9.97%

Dividend

Aug 05, 20240.208 USD/sh

Earnings

Feb 26, 2025

Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

URL

https://www.reckitt.com/

IPO date

Oct 23, 2007

Employees

40,000

Domiciled in

Incorporated in

Valuation

Order:

Title GBP in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title GBP in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	14,607,000 1.07%	14,453,000 9.21%	13,234,000 -5.42%
Cost of revenue	11,269,000	11,060,000	10,507,000
Unusual Expense (Income)
NOPBT	3,338,000	3,393,000	2,727,000
NOPBT Margin	22.85%	23.48%	20.61%
Operating Taxes	753,000	711,000	208,000
Tax Rate	22.56%	20.95%	7.63%
NOPAT	2,585,000	2,682,000	2,519,000
Net income	1,643,000 -29.48%	2,330,000 -3,798.41%	(63,000) -105.31%
Dividends	(1,339,000)	(1,249,000)	(1,246,000)
Dividend yield	3.44%	3.03%	2.75%
Proceeds from repurchase of equity	(161,000)	54,000	75,000
BB yield	0.41%	-0.13%	-0.17%
Debt
Debt current	1,679,000	1,721,000	2,485,000
Long-term debt	7,185,000	7,552,000	7,078,000
Deferred revenue			4,006,000
Other long-term liabilities	572,000	718,000	(6,812,000)
Net debt	7,359,000	8,030,000	8,108,000
Cash flow
Cash from operating activities	2,636,000	2,397,000	1,697,000
CAPEX	(348,000)	(443,000)	(373,000)
Cash from investing activities	(466,000)	(139,000)	239,000
Cash from financing activities	(1,809,000)	(2,380,000)	(2,286,000)
FCF	3,274,000	1,789,000	2,311,000
Balance
Cash	1,387,000	1,157,000	1,261,000
Long term investments	118,000	86,000	194,000
Excess cash	774,650	520,350	793,300
Stockholders' equity	22,444,000	23,752,000	22,618,000
Invested Capital	16,803,350	17,773,650	17,650,700
ROIC	14.95%	15.14%	13.25%
ROCE	16.30%	15.91%	12.83%
EV
Common stock shares outstanding	718,284	717,495	713,759
Price	54.20 -5.80%	57.54 -9.27%	63.42 -3.06%
Market cap	38,930,968 -5.70%	41,284,640 -8.80%	45,266,590 -3.06%
EV	46,310,968	49,648,640	54,617,590
EBITDA	3,808,000	4,000,000	3,090,000
EV/EBITDA	12.16	12.41	17.68
Interest	318,000	257,000	264,000
Interest/NOPBT	9.53%	7.57%	9.68%